Abstract

From novel insights in molecular biology to targeted treatment approaches in head and neck cancer

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Epidermal growth factor receptor-inhibitors and radiotherapy-induced cutaneous adverse effects: “Koebner-Phenomenon” or radio-dermatitis?
Marco C Merlano
Radiotherapy and Oncology | VOL. 92
Marco C MerlanoMarco C Merlano
26 Mar 2009
Acceler-Dated Fractionation: The End of the Era of the Large, “One Size Fits All” Trial for Locally Advanced Head and Neck Cancer
Quynh-Thu Le ... Mitchell Machtay
International Journal of Radiation Oncology, Biology, Physics | VOL. 89
Quynh-Thu Le, et. al.Quynh-Thu Le ... Mitchell Machtay
10 Apr 2014
Quality of life and its correlates in pretreatment patients with locally advanced head and neck cancer: A cross-sectional study in Thailand.
Yaowarat Matchim ... Kiratiya Wongkalasin
Belitung nursing journal | VOL. 9
Yaowarat Matchim, et. al.Yaowarat Matchim ... Kiratiya Wongkalasin
26 Jun 2023
Impact of cetuximab on chemoradiation use in older patients with locally advanced head and neck cancer.
David G Pfister ... Shrujal S Baxi
Journal of Clinical Oncology | VOL. 31
David G Pfister, et. al.David G Pfister ... Shrujal S Baxi
20 May 2013
View more papers

More From: EJC Supplements

Paper Title
Journal
Date
Author
Can the peptide receptor radionuclide therapy [177Lu]Lu-DOTA-TATE provide a net benefit for NET patients?
Martyn E Caplin
EJC Supplements | VOL. 16
Martyn E CaplinMartyn E Caplin
01 Nov 2021
Editorial board
-
EJC Supplements | VOL. 16
--
01 Nov 2021
Use of [177Lu]Lu-DOTA-TATE in the treatment of gastroenteropancreatic neuroendocrine tumours: Results of a UK cost-effectiveness modelling study
Matthew Glover ... Oscar R Leeuwenkamp
EJC Supplements | VOL. 16
Matthew Glover, et. al.Matthew Glover ... Oscar R Leeuwenkamp
01 Nov 2021
Matching-adjusted indirect treatment comparison of [177Lu]Lu-DOTA-TATE, everolimus and sunitinib in advanced, unresectable gastroenteropancreatic neuroendocrine tumours: Relative effectiveness of [177Lu]Lu-DOTA-TATE in gastroenteropancreatic neuroendocrine tumours
Elaine Stamp ... Tessa Brabander
EJC Supplements | VOL. 16
Elaine Stamp, et. al.Elaine Stamp ... Tessa Brabander
01 Nov 2021
View more papers